Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Frontiers in Pharmacology|May 8, 2018
Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR TechniqueMichele Marangi, Giuseppa PistrittoCancers|February 25, 2023
HIPK2 as a Novel Regulator of FibrosisAlessia Garufi, Giuseppa Pistritto, Gabriella D'OraziDrug Discovery Today|May 4, 2019
The Horizon Scanning System at The Italian Medicines AgencyMichele Marangi, Jelena Ivanovic, Giuseppa PistrittoNeurotoxicology|January 24, 2015
A not cytotoxic nickel concentration alters the expression of neuronal differentiation markers in NT2 cellsClaudia Ceci, Maria Luisa Barbaccia, Giuseppa PistrittoMaterials Science & Engineering. C, Materials for Biological Applications|September 10, 2017
Neuro-differentiated Ntera2 cancer stem cells encapsulated in alginate beads: First evidence of biological functionalityIlaria Cacciotti, Claudia Ceci, Alessandra Bianco, et al.Gynecologic Oncology|April 9, 2008
Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cellsRosa Puca, Lavinia Nardinocchi, Giuseppa Pistritto, et al.Journal of Experimental & Clinical Cancer Research : CR|September 8, 2016
Reactivation of mutant p53 by capsaicin, the major constituent of peppersAlessia Garufi, Giuseppa Pistritto, Mara Cirone, et al.Cancers|March 11, 2023
HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic DiseasesAlessia Garufi, Valerio D'Orazi, Giuseppa Pistritto, et al.Aging|March 29, 2016
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategiesGiuseppa Pistritto, Daniela Trisciuoglio, Claudia Ceci, et al.Biomolecules|March 25, 2022
The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot StudyAlessia Garufi, Giuseppa Pistritto, Valerio D'Orazi, et al.Pageof 3